Testosterone Propionate vs Undecanoate: Pharmacokinetics, Injection Protocol, and Blood Test Timing

Testosterone propionate (Test P) and injectable testosterone undecanoate (Nebido/Aveed) are the two extremes of the injectable testosterone ester spectrum. Understanding their differences illuminates the full range of pharmacokinetic options available, and why intermediate-acting esters like enanthate and cypionate have become the practical standard for most users.

Testosterone propionate has a half-life of approximately 0.8 to 2 days. It peaks within hours of injection, clears completely within 7 to 10 days of the last dose, and requires daily or every-other-day (EOD) injections to maintain stable levels. Its rapid onset and fast clearance make it a tool for specific short-term scenarios in bodybuilding.

Injectable testosterone undecanoate (Nebido/Aveed) has a half-life of approximately 20 to 21 days. A single injection at 1,000 mg sustains testosterone levels for 10 to 14 weeks. It is designed exclusively for TRT, where reducing injection burden to 4 to 5 times per year is the primary goal.

These two esters are rarely compared clinically because they serve entirely different populations and purposes. However, understanding why they represent the extremes helps clarify why medium-acting esters (enanthate, cypionate) occupy the practical middle ground for the majority of TRT patients and performance-oriented users.

Note: this comparison covers injectable testosterone undecanoate only. Oral testosterone undecanoate (Andriol, Jatenzo) has a different pharmacokinetic profile.

Ester chain length and half-life:

• Propionate: 3-carbon ester (propionic acid), half-life approximately 0.8 to 2 days
• Undecanoate: 11-carbon ester (undecanoic acid), half-life approximately 20 to 21 days
• This is the largest half-life differential among the commonly discussed testosterone esters: undecanoate lasts approximately 10 to 25 times longer than propionate

Peak serum levels:

• Propionate: peaks at approximately 3 hours post-injection, one of the fastest peaks among all testosterone formulations. This rapid spike is followed by a steep decline.
• Undecanoate: peaks at approximately 7 days post-injection (range 3 to 14 days), reflecting the slow depot release from the large-volume oil formulation.

Injection frequency:

• Propionate: every other day (EOD minimum) to daily. At EOD dosing, levels drop by approximately 50 to 70% between injections. Daily dosing is required for truly stable levels.
• Undecanoate: loading injections at week 0 and week 6, then every 10 to 14 weeks for maintenance.

Steady-state timeline:

• Propionate: reaches steady state in approximately 1 week due to the short half-life
• Undecanoate: requires approximately 30 weeks to reach true steady state, with a mandatory loading phase to accelerate approach to therapeutic levels

Dose flexibility and adjustability:

• Propionate: maximum flexibility. Each injection can be a different dose. Effects of dose changes are apparent within days. Discontinuation results in near-complete clearance within 7 to 10 days.
• Undecanoate: essentially no flexibility within a cycle. Dose adjustment is made only by changing the inter-injection interval (earlier or later than scheduled). The effect of any adjustment takes many weeks to manifest.

Blood draw timing for accurate readings:

• Propionate: draw at 12 to 24 hours after the last injection on an EOD or daily protocol. Trough testing is unreliable because a small shift in injection timing dramatically changes the result. Always document exact hours elapsed since the last injection.
• Undecanoate: two reference points. Mid-interval draw (approximately week 6 of a 12-week schedule) reflects average levels. Trough draw (week 10 to 14, immediately before the next injection) reflects the nadir and determines whether the interval needs shortening. Document the exact date of the last injection at every blood draw.

Post-cycle clearance and PCT implications:

• Propionate: clears within 7 to 10 days. PCT agents (clomiphene, nolvadex) can be started as early as 3 to 5 days after the last injection, making propionate highly suitable for structured post-cycle therapy.
• Undecanoate: takes many months to clear (5 half-lives is approximately 100 to 105 days from the last injection, assuming no further doses). PCT is impractical after undecanoate without either waiting several months or intervening medically.

Aromatisation and oestrogen pattern:

• Propionate: produces rapid oestradiol spikes following each injection that resolve quickly between doses. The compressed injection cycle can produce fluctuating oestrogen levels, though some users report less overall water retention compared to longer esters.
• Undecanoate: produces a slow, broad oestradiol curve that tracks the extended release profile. Oestrogen levels are more stable but harder to manage over long intervals if aromatase inhibition is needed.

Choose testosterone propionate for:

• Contest prep and pre-competition phases: the fast clearance allows testosterone to be tapered out before a drug-tested event or competition
• Short cycles (6 to 8 weeks): rapid onset maximises productive cycle time, and fast clearance shortens the post-cycle recovery period
• Fine-grained hormonal control: dose can be adjusted injection-to-injection with effects measurable within days
• PCT-planned protocols: propionate's fast washout allows PCT to begin within days of the last injection
• Sensitive individuals who want rapid discontinuation as an option if side effects emerge

Choose injectable testosterone undecanoate for:

• Long-term TRT with minimal injection burden: quarterly injections are a major quality-of-life advantage for appropriate patients
• Patients managed in a clinic setting where injections are administered by healthcare professionals
• Countries or formularies where undecanoate is the primary available injectable TRT option
• Patients for whom weekly injections are genuinely impractical due to lifestyle, disability, or compliance challenges

When neither is appropriate (and enanthate or cypionate should be chosen instead):

• Standard TRT where dose flexibility and simple blood test monitoring are both needed (enanthate or cypionate)
• Long enhancement cycles where injection frequency must be manageable but pharmacokinetics need to be predictable (enanthate or cypionate)
• Most recreational bodybuilding scenarios

Blood test timing implications:

• Propionate users must standardise their draw time to a fixed interval post-injection (12 to 24 hours recommended). Any deviation in timing makes results incomparable across visits.
• Undecanoate users must log injection dates and provide them with every blood draw. Without exact injection timing, serum testosterone results are uninterpretable. Mid-interval and trough measurements serve different clinical purposes and should ideally both be obtained when adjusting a protocol.